{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:33:13Z","timestamp":1792427593223,"version":"4.5.0"},"reference-count":111,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnologia CONACyT","doi-asserted-by":"publisher","award":["A1-S-13656"],"award-info":[{"award-number":["A1-S-13656"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Endometrial cancer represents the most frequent neoplasia from the corpus uteri, and comprises the 14th leading cause of death in women worldwide. Risk factors that contribute to the disease include early menarche, late menopause, nulliparity, and menopausal hormone use, as well as hypertension and obesity comorbidities. The clinical effectiveness of chemotherapy is variable, suggesting that novel molecular targeted therapies against specific cellular processes associated with the maintenance of cancer cell survival and therapy resistance urged to ameliorate the rates of success in endometrial cancer treatment. In the course of tumor growth, cancer cells must adapt to decreased oxygen availability in the microenvironment by upregulation of hypoxia-inducible factors, which orchestrate the activation of a transcriptional program leading to cell survival. During this adaptative process, the hypoxic cancer cells may acquire invasive and metastatic properties as well as increased cell proliferation and resistance to chemotherapy, enhanced angiogenesis, vasculogenic mimicry, and maintenance of cancer cell stemness, which contribute to more aggressive cancer phenotypes. Several studies have shown that hypoxia-inducible factor 1 alpha (HIF-1\u03b1) protein is aberrantly overexpressed in many solid tumors from breast, prostate, ovarian, bladder, colon, brain, and pancreas. Thus, it has been considered an important therapeutic target. Here, we reviewed the current knowledge of the relevant roles of cellular hypoxia mechanisms and HIF-1\u03b1 functions in diverse processes associated with endometrial cancer progression. In addition, we also summarize the role of microRNAs in the posttranscriptional regulation of protein-encoding genes involved in the hypoxia response in endometrial cancer. Finally, we pointed out the need for urgent targeted therapies to impair the cellular processes activated by hypoxia in the tumor microenvironment.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389201022666210224130022","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T04:37:48Z","timestamp":1614227868000},"page":"221-234","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Role of Hypoxia in Endometrial Cancer"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2129-9980","authenticated-orcid":true,"given":"Yarely M.","family":"Salinas-Vera","sequence":"first","affiliation":[{"name":"Departamento de Bioqu\u00edmica, CINVESTAV-IPN, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0628-8290","authenticated-orcid":true,"given":"Dolores","family":"Gallardo-Rinc\u00f3n","sequence":"additional","affiliation":[{"name":"Laboratorio de Medicina Traslacional y\nDepartamento de Tumores Gastrointestinales, Instituto Nacional de Cancerolog\u00eda, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0446-123X","authenticated-orcid":true,"given":"Erika","family":"Ru\u00edz-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Laboratorio de Medicina Traslacional y Departamento de Tumores Gastrointestinales, Instituto Nacional de Cancerolog\u00eda, Ciudad de M\u00e9xico, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0277-0186","authenticated-orcid":true,"given":"Macrina B.","family":"Silva-C\u00e1zares","sequence":"additional","affiliation":[{"name":"Doctorado Institucional en Ingenier\u00eda y Ciencia de Materiales, Universidad Aut\u00f3noma de San Luis Potos\u00ed, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5036-553X","authenticated-orcid":true,"given":"Carmen Sol","family":"de la Pe\u00f1a-Cruz","sequence":"additional","affiliation":[{"name":"Instituto Educativo Panamericano, Xalapa, Veracruz, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9417-2609","authenticated-orcid":true,"given":"C\u00e9sar","family":"L\u00f3pez-Camarillo","sequence":"additional","affiliation":[{"name":"Posgrado en Ciencias Gen\u00f3micas, Universidad\nAut\u00f3noma de la Ciudad de M\u00e9xico, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"Bray F.","year":"2018","unstructured":"Bray F.; Ferlay J.; Soerjomataram I.; Siegel R.L.; Torre L.A.; Jemal A.; Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018,68(6),394-424","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/jnci\/djx214","volume":"110","author":"Lortet-Tieulent J.","year":"2018","unstructured":"Lortet-Tieulent J.; Ferlay J.; Bray F.; Jemal A.; International patterns and trends in endometrial cancer incidence, 1978-2013. J Natl Cancer Inst 2018,110(4),354-361","journal-title":"J Natl Cancer Inst"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.14694\/EDBK_175666","volume":"37","author":"Moore K.","year":"2017","unstructured":"Moore K.; Brewer M.A.; Endometrial Cancer: Is This a New Disease? Am Soc Clin Oncol Educ Book 2017,37,435-442","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1200\/JCO.2016.67.9712","volume":"34","author":"Hopkins B.D.","year":"2016","unstructured":"Hopkins B.D.; Goncalves M.D.; Cantley L.C.; Obesity and Cancer Mechanisms: Cancer Metabolism. J Clin Oncol 2016,34(35),4277-4283","journal-title":"J Clin Oncol"},{"key":"ref=5","author":"Stewart B.W.","unstructured":"Stewart B.W.; Wild C.;  International Agency for Research on\nCancer, World Health Organization, editorsWorld cancer report\n2014 3rd ed; International Agency for Research on Cancer: Lyon,\nFrance, 2014, p 630","journal-title":"International Agency for Research on\nCancer, World Health Organization, editorsWorld cancer report\n2014 3rd ed; International Agency for Research on Cancer: Lyon,\nFrance, 2014, p 630"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","volume":"377","author":"Finucane M.M.","year":"2011","unstructured":"Finucane M.M.; Stevens G.A.; Cowan M.J.; Danaei G.; Lin J.K.; Paciorek C.J.; Singh G.M.; Gutierrez H.R.; Lu Y.; Bahalim A.N.; Farzadfar F.; Riley L.M.; Ezzati M.; Global Burden\nof Metabolic Risk Factors of Chronic Diseases Collaborating\nGroup (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9\u20221 million participants. Lancet 2011,377(9765),557-567","journal-title":"Lancet"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1470-2045(14)71123-4","volume":"16","author":"Arnold M.","year":"2015","unstructured":"Arnold M.; Pandeya N.; Byrnes G.; Renehan P.A.G.; Stevens G.A.; Ezzati P.M.; Ferlay J.; Miranda J.J.; Romieu I.; Dikshit R.; Forman D.; Soerjomataram I.; Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol 2015,16(1),36-46","journal-title":"Lancet Oncol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","volume":"31","author":"Setiawan V.W.","year":"2013","unstructured":"Setiawan V.W.; Yang H.P.; Pike M.C.; McCann S.E.; Yu H.; Xiang Y-B.; Wolk A.; Wentzensen N.; Weiss N.S.; Webb P.M.; van den Brandt P.A.; van de Vijver K.; Thompson P.J.; Strom B.L.; Spurdle A.B.; Soslow R.A.; Shu X.O.; Schairer C.; Sacerdote C.; Rohan T.E.; Robien K.; Risch H.A.; Ricceri F.; Rebbeck T.R.; Rastogi R.; Prescott J.; Polidoro S.; Park Y.; Olson S.H.; Moysich K.B.; Miller A.B.; McCullough M.L.; Matsuno R.K.; Magliocco A.M.; Lurie G.; Lu L.; Lissowska J.; Liang X.; Lacey J.V.; Kolonel L.N.; Henderson B.E.; Hankinson S.E.; H&#xE5;kansson N.; Goodman M.T.; Gaudet M.M.; Garcia-Closas M.; Friedenreich C.M.; Freudenheim J.L.; Doherty J.; De Vivo I.; Courneya K.S.; Cook L.S.; Chen C.; Cerhan J.R.; Cai H.; Brinton L.A.; Bernstein L.; Anderson K.E.; Anton-Culver H.; Schouten L.J.; Horn-Ross P.L.; Australian National Endometrial Cancer Study Group. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 2013,31(20),2607-2618","journal-title":"J Clin Oncol"},{"key":"ref=9","unstructured":"National Cancer Institute Cancer of the Endometrium - Cancer Stat Facts SEER,  https:\/\/seer.cancer.gov\/statfacts\/html\/corp.html[cited 2020 Oct 13]. Available from:","journal-title":"National Cancer Institute Cancer of the Endometrium - Cancer Stat Facts SEER,"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc3878","volume":"15","author":"Lynch H.T.","year":"2015","unstructured":"Lynch H.T.; Snyder C.L.; Shaw T.G.; Heinen C.D.; Hitchins M.P.; Milestones of Lynch syndrome: 1895-2015. Nat Rev Cancer 2015,15(3),181-194","journal-title":"Nat Rev Cancer"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/path.4185","volume":"230","author":"Briggs S.","year":"2013","unstructured":"Briggs S.; Tomlinson I.; Germline and somatic polymerase &#x3B5; and &#x3B4; mutations define a new class of hypermutated colorectal and endometrial cancers. J Pathol 2013,230(2),148-153","journal-title":"J Pathol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1200\/JCO.2013.53.6656","volume":"32","author":"Ngeow J.","year":"2014","unstructured":"Ngeow J.; Stanuch K.; Mester J.L.; Barnholtz-Sloan J.S.; Eng C.; Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations. J Clin Oncol 2014,32(17),1818-1824","journal-title":"J Clin Oncol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1634\/theoncologist.2016-0062","volume":"21","author":"Bestvina C.M.","year":"2016","unstructured":"Bestvina C.M.; Fleming G.F.; Chemotherapy for endometrial cancer in adjuvant and advanced disease settings. Oncologist 2016,21(10),1250-1259","journal-title":"Oncologist"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1590\/S1984-82502014000400004","volume":"50","author":"Sousa G.","year":"2014","unstructured":"Sousa G.; F de.; Wlodarczyk, S.R.; Monteiro, G. Carboplatin: molecular mechanisms of action associated with chemoresistance. Braz J Pharm Sci 2014,50(4),693-701","journal-title":"Braz J Pharm Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41568-019-0177-x","volume":"19","author":"Urick M.E.","year":"2019","unstructured":"Urick M.E.; Bell D.W.; Clinical actionability of molecular targets in endometrial cancer. Nat Rev Cancer 2019,19(9),510-521","journal-title":"Nat Rev Cancer"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"Wang G.L.","year":"1995","unstructured":"Wang G.L.; Jiang B.H.; Rue E.A.; Semenza G.L.; Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995,92(12),5510-5514","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"Harris A.L.","year":"2002","unstructured":"Harris A.L.; Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer 2002,2(1),38-47","journal-title":"Nat Rev Cancer"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","volume":"33","author":"Semenza G.L.","year":"2012","unstructured":"Semenza G.L.; Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 2012,33(4),207-214","journal-title":"Trends Pharmacol Sci"},{"key":"ref=19","first-page":"7106","volume":"60","author":"Blancher C.","year":"2000","unstructured":"Blancher C.; Moore J.W.; Talks K.L.; Houlbrook S.; Harris A.L.; Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res 2000,60(24),7106-7113","journal-title":"Cancer Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","volume":"148","author":"Semenza G.L.","year":"2012","unstructured":"Semenza G.L.; Hypoxia-inducible factors in physiology and medicine. Cell 2012,148(3),399-408","journal-title":"Cell"},{"key":"ref=21","first-page":"175","author":"Xiang L.","year":"2019","unstructured":"Xiang L.; Semenza G.L.;  Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy Advances in Cancer Research 2019,175-212","journal-title":"Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy Advances in Cancer Research"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1126\/science.1066373","volume":"294","author":"Bruick R.K.","year":"2001","unstructured":"Bruick R.K.; McKnight S.L.; A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001,294(5545),1337-1340","journal-title":"Science"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","volume":"30","author":"Kaelin W.G.","year":"2008","unstructured":"Kaelin W.G.; Ratcliffe P.J.; Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008,30(4),393-402","journal-title":"Mol Cell"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"Ivan M.","year":"2001","unstructured":"Ivan M.; Kondo K.; Yang H.; Kim W.; Valiando J.; Ohh M.; Salic A.; Asara J.M.; Lane W.S.; Kaelin W.G.; Jr HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001,292(5516),464-468","journal-title":"Science"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.1093\/emboj\/19.16.4298","volume":"19","author":"Tanimoto K.","year":"2000","unstructured":"Tanimoto K.; Makino Y.; Pereira T.; Poellinger L.; Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J 2000,19(16),4298-4309","journal-title":"EMBO J"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"Jaakkola P.","year":"2001","unstructured":"Jaakkola P.; Mole D.R.; Tian Y-M.; Wilson M.I.; Gielbert J.; Gaskell S.J.; von Kriegsheim A.; Hebestreit H.F.; Mukherji M.; Schofield C.J.; Maxwell P.H.; Pugh C.W.; Ratcliffe P.J.; Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001,292(5516),468-472","journal-title":"Science"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrm1366","volume":"5","author":"Schofield C.J.","year":"2004","unstructured":"Schofield C.J.; Ratcliffe P.J.; Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004,5(5),343-354","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"Maxwell P.H.","year":"1999","unstructured":"Maxwell P.H.; Wiesener M.S.; Chang G-W.; Clifford S.C.; Vaux E.C.; Cockman M.E.; Wykoff C.C.; Pugh C.W.; Maher E.R.; Ratcliffe P.J.; The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999,399(6733),271-275","journal-title":"Nature"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10911-010-9173-1","volume":"15","author":"Creighton C.J.","year":"2010","unstructured":"Creighton C.J.; Chang J.C.; Rosen J.M.; Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia 2010,15(2),253-260","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.canlet.2018.06.003","volume":"432","author":"Salinas-Vera Y.M.","year":"2018","unstructured":"Salinas-Vera Y.M.; Marchat L.A.; Garc&#xED;a-V&#xE1;zquez R.; Gonz&#xE1;lez de la Rosa C.H.; Casta&#xF1;eda-Saucedo E.; Tito N.N.; Flores C.P.; P&#xE9;rez-Plasencia C.; Cruz-Colin J.L.; Carlos-Reyes &#xC1;.; L&#xF3;pez-Gonz&#xE1;lez J.S.; &#xC1;lvarez-S&#xE1;nchez M.E.; L&#xF3;pez-Camarillo C.; Cooperative multi-targeting of signaling networks by angiomiR-204 inhibits vasculogenic mimicry in breast cancer cells. Cancer Lett 2018,432,17-27","journal-title":"Cancer Lett"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","volume":"155","author":"Maniotis A.J.","year":"1999","unstructured":"Maniotis A.J.; Folberg R.; Hess A.; Seftor E.A.; Gardner L.M.G.; Pe\u2019er J.; Trent J.M.; Meltzer P.S.; Hendrix M.J.; Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999,155(3),739-752","journal-title":"Am J Pathol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fonc.2019.00381","volume":"9","author":"Salinas-Vera Y.M.","year":"2019","unstructured":"Salinas-Vera Y.M.; Gallardo-Rinc&#xF3;n D.; Garc&#xED;a-V&#xE1;zquez R.; Hern&#xE1;ndez-de la Cruz O.N.; Marchat L.A.; Gonz&#xE1;lez-Barrios J.A.; Ru&#xED;z-Garc&#xED;a E.; V&#xE1;zquez-Calzada C.; Contreras-Sanz&#xF3;n E.; Resendiz-Hern&#xE1;ndez M.; Astudillo-de la Vega H.; Cruz-Colin J.L.; Campos-Parra A.D.; L&#xF3;pez-Camarillo C.; HypoxamiRs profiling identify miR-765 as a regulator of the early stages of vasculogenic mimicry in SKOV3 ovarian cancer cells. Front Oncol 2019,9,381","journal-title":"Front Oncol"},{"key":"ref=33","first-page":"3250","volume":"61","author":"Hess A.R.","year":"2001","unstructured":"Hess A.R.; Seftor E.A.; Gardner L.M.; Carles-Kinch K.; Schneider G.B.; Seftor R.E.; Kinch M.S.; Hendrix M.J.; Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck\/EphA2). Cancer Res 2001,61(8),3250-3255","journal-title":"Cancer Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"R69","DOI":"10.1186\/bcr1626","volume":"8","author":"Basu G.D.","year":"2006","unstructured":"Basu G.D.; Liang W.S.; Stephan D.A.; Wegener L.T.; Conley C.R.; Pockaj B.A.; Mukherjee P.; A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells. Breast Cancer Res 2006,8(6),R69","journal-title":"Breast Cancer Res"},{"key":"ref=35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099907","volume":"9","author":"Liao Y.","year":"2014","unstructured":"Liao Y.; Lu W.; Che Q.; Yang T.; Qiu H.; Zhang H.; He X.; Wang J.; Qiu M.; Zou Y.; Gu W.; Wan X.; SHARP1 suppresses angiogenesis of endometrial cancer by decreasing hypoxia-inducible factor-1&#x3B1; level. PLoS One 2014,9(6)","journal-title":"PLoS One"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"E2047","DOI":"10.1073\/pnas.1602883113","volume":"113","author":"Zhang C.","year":"2016","unstructured":"Zhang C.; Samanta D.; Lu H.; Bullen J.W.; Zhang H.; Chen I.; He X.; Semenza G.L.; Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA. Proc Natl Acad Sci USA 2016,113(14),E2047-E2056","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=37","first-page":"21","author":"Li Z.","year":"2010","unstructured":"Li Z.; Rich J.N.;  Hypoxia and hypoxia inducible factors in cancer stem cell maintenance in current topics in microbiology and immunology 2010,21-30","journal-title":"Hypoxia and hypoxia inducible factors in cancer stem cell maintenance in current topics in microbiology and immunology"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.bbamcr.2015.05.036","volume":"1863","author":"Semenza G.L.","year":"2016","unstructured":"Semenza G.L.; The hypoxic tumor microenvironment: A driving force for breast cancer progression. Biochim Biophys Acta 2016,1863(3),382-391","journal-title":"Biochim Biophys Acta"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1172\/JCI30487","volume":"117","author":"Higgins D.F.","year":"2007","unstructured":"Higgins D.F.; Kimura K.; Bernhardt W.M.; Shrimanker N.; Akai Y.; Hohenstein B.; Saito Y.; Johnson R.S.; Kretzler M.; Cohen C.D.; Eckardt K.U.; Iwano M.; Haase V.H.; Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007,117(12),3810-3820","journal-title":"J Clin Invest"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13046-018-0787-2","volume":"37","author":"Chen X.","year":"2018","unstructured":"Chen X.; Zhang S.; Wang Z.; Wang F.; Cao X.; Wu Q.; Zhao C.; Ma H.; Ye F.; Wang H.; Fang Z.; Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA\/ROCK-ERK\/p38 pathway. J Exp Clin Cancer Res 2018,37(1),128","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/modpathol.3800718","volume":"20","author":"Pansare V.","year":"2007","unstructured":"Pansare V.; Munkarah A.R.; Schimp V.; Haitham Arabi M.; Saed G.M.; Morris R.T.; Ali-Fehmi R.; Increased expression of hypoxia-inducible factor 1&#x3B1; in type I and type II endometrial carcinomas. Mod Pathol 2007,20(1),35-43","journal-title":"Mod Pathol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1126\/science.1073440","volume":"296","author":"Min J-H.","year":"2002","unstructured":"Min J-H.; Yang H.; Ivan M.; Gertler F.; Kaelin W.G.; Pavletich N.P.; Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Science 2002,296(5574),1886-1889","journal-title":"Science"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"9907","DOI":"10.2147\/CMAR.S223421","volume":"11","author":"Zhu C.","year":"2019","unstructured":"Zhu C.; Ding H.; Yang J.; Zhou Y.; Luo Y.; Shi S.; Zhang Y.; Wei Y.; Ni G.; Downregulation of Proline Hydroxylase 2 and Upregulation of Hypoxia-Inducible Factor 1&#x3B1; are Associated with Endometrial Cancer Aggressiveness. Cancer Manag Res 2019,11,9907-9912","journal-title":"Cancer Manag Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000100477","volume":"71","author":"Fujimoto J.","year":"2006","unstructured":"Fujimoto J.; Sato E.; Alam S.M.; Jahan I.; Toyoki H.; Hong B.L.; Sakaguchi H.; Tamaya T.; Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers. Oncology 2006,71(1-2),95-101","journal-title":"Oncology"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3892\/or.17.4.871","volume":"17","author":"Yunokawa M.","year":"2007","unstructured":"Yunokawa M.; Tanimoto K.; Nakamura H.; Nagai N.; Kudo Y.; Kawamoto T.; Kato Y.; Hiyama E.; Hiyama K.; Nishiyama M.; Differential regulation of DEC2 among hypoxia-inducible genes in endometrial carcinomas. Oncol Rep 2007,17(4),871-878","journal-title":"Oncol Rep"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/jcp.2007.046680","volume":"61","author":"Giatromanolaki A.","year":"2008","unstructured":"Giatromanolaki A.; Koukourakis M.I.; Gatter K.C.; Harris A.L.; Sivridis E.; BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1alpha pathway and prognosis. J Clin Pathol 2008,61(2),217-220","journal-title":"J Clin Pathol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.ctrv.2015.11.001","volume":"41","author":"Meng X.","year":"2015","unstructured":"Meng X.; Huang Z.; Teng F.; Xing L.; Yu J.; Predictive biomarkers in PD-1\/PD-L1 checkpoint blockade immunotherapy. Cancer Treat Rev 2015,41(10),868-876","journal-title":"Cancer Treat Rev"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"S1063","DOI":"10.4103\/0973-1482.202891","volume":"14","author":"Tawadros A.I.F.","year":"2018","unstructured":"Tawadros A.I.F.; Khalafalla M.M.M.; Expression of programmed death-ligand 1 and hypoxia-inducible factor-1&#x3B1; proteins in endometrial carcinoma. J Cancer Res Ther 2018,14(7)(Suppl.),S1063-S1069","journal-title":"J Cancer Res Ther"},{"key":"ref=49","first-page":"218","volume":"4","author":"Green S.L.","year":"1998","unstructured":"Green S.L.; Giaccia A.J.; Tumor hypoxia and the cell cycle: implications for malignant progression and response to therapy. Cancer J Sci Am 1998,4(4),218-223","journal-title":"Cancer J Sci Am"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature03094","volume":"432","author":"Massagu&#xE9; J.","year":"2004","unstructured":"Massagu&#xE9; J.; G1 cell-cycle control and cancer. Nature 2004,432(7015),298-306","journal-title":"Nature"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1006\/gyno.2000.5814","volume":"77","author":"Schmitz M.J.","year":"2000","unstructured":"Schmitz M.J.; Hendricks D.T.; Farley J.; Taylor R.R.; Geradts J.; Rose G.S.; Birrer M.J.; p27 and cyclin D1 abnormalities in uterine papillary serous carcinoma. Gynecol Oncol 2000,77(3),439-445","journal-title":"Gynecol Oncol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/path.2244","volume":"214","author":"Horr&#xE9;e N.","year":"2008","unstructured":"Horr&#xE9;e N.; Gort E.H.; van der Groep P.; Heintz A.P.; Vooijs M.; van Diest P.J.; Hypoxia-inducible factor 1 &#x3B1; is essential for hypoxic p27 induction in endometrioid endometrial carcinoma. J Pathol 2008,214(1),38-45","journal-title":"J Pathol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/1471-2407-10-307","volume":"10","author":"Seeber L.M.","year":"2010","unstructured":"Seeber L.M.; Horr&#xE9;e N.; van der Groep P.; van der Wall E.; Verheijen R.H.; van Diest P.J.; Necrosis related HIF-1&#x3B1; expression predicts prognosis in patients with endometrioid endometrial carcinoma. BMC Cancer 2010,10(1),307","journal-title":"BMC Cancer"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4161\/cc.3.2.618","volume":"3","author":"Potter C.","year":"2004","unstructured":"Potter C.; Harris A.L.; Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target. Cell Cycle 2004,3(2),164-167","journal-title":"Cell Cycle"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1677\/joe.1.05599","volume":"183","author":"Hayashi M.","year":"2004","unstructured":"Hayashi M.; Sakata M.; Takeda T.; Yamamoto T.; Okamoto Y.; Sawada K.; Kimura A.; Minekawa R.; Tahara M.; Tasaka K.; Murata Y.; Induction of glucose transporter 1 expression through hypoxia-inducible factor 1&#x3B1; under hypoxic conditions in trophoblast-derived cells. J Endocrinol 2004,183(1),145-154","journal-title":"J Endocrinol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"Liberti M.V.","year":"2016","unstructured":"Liberti M.V.; Locasale J.W.; The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem Sci 2016,41(3),211-218","journal-title":"Trends Biochem Sci"},{"key":"ref=57","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/616850","author":"Sadlecki P.","year":"2014","unstructured":"Sadlecki P.; Bodnar M.; Grabiec M.; Marszalek A.; Walentowicz P.; Sokup A.; Zegarska J.; Walentowicz-Sadlecka M.; The role of Hypoxia-inducible factor-1 &#x3B1;, glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients. BioMed Res Int 2014","journal-title":"BioMed Res Int"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"152","DOI":"10.7150\/jca.5702","volume":"4","author":"Singh H.","year":"2013","unstructured":"Singh H.; Li Y.; Fuller P.J.; Harrison C.; Rao J.; Stephens A.N.; Nie G.; HtrA3 is downregulated in cancer cell lines and significantly reduced in primary serous and granulosa cell ovarian tumors. J Cancer 2013,4(2),152-164","journal-title":"J Cancer"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1016\/j.bbrc.2018.08.070","volume":"503","author":"Lv Q.","year":"2018","unstructured":"Lv Q.; Yang B.; Ning C.; Xie B.; Nie G.; Chen X.; Chen Q.; Hypoxia is involved in the reduction of HtrA3 in patients with endometrial hyperplasia and cancer. Biochem Biophys Res Commun 2018,503(4),2918-2923","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"Hanahan D.","year":"2000","unstructured":"Hanahan D.; Weinberg R.A.; The hallmarks of cancer. Cell 2000,100(1),57-70","journal-title":"Cell"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"Hanahan D.","year":"2011","unstructured":"Hanahan D.; Weinberg R.A.; Hallmarks of cancer: the next generation. Cell 2011,144(5),646-674","journal-title":"Cell"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrc.2016.84","volume":"16","author":"Nakazawa M.S.","year":"2016","unstructured":"Nakazawa M.S.; Keith B.; Simon M.C.; Oxygen availability and metabolic adaptations. Nat Rev Cancer 2016,16(10),663-673","journal-title":"Nat Rev Cancer"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"Pavlova N.N.","year":"2016","unstructured":"Pavlova N.N.; Thompson C.B.; The Emerging Hallmarks of Cancer Metabolism. Cell Metab 2016,23(1),27-47","journal-title":"Cell Metab"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","volume":"38","author":"Pastorekova S.","year":"2019","unstructured":"Pastorekova S.; Gillies R.J.; The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond. Cancer Metastasis Rev 2019,38(1-2),65-77","journal-title":"Cancer Metastasis Rev"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s12013-013-9650-4","volume":"67","author":"Hong X-Y.","year":"2013","unstructured":"Hong X-Y.; Wang J.; Li Z.; AGR2 expression is regulated by HIF-1 and contributes to growth and angiogenesis of glioblastoma. Cell Biochem Biophys 2013,67(3),1487-1495","journal-title":"Cell Biochem Biophys"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"31459","DOI":"10.18632\/oncotarget.25838","volume":"9","author":"Kamal A.","year":"2018","unstructured":"Kamal A.; Valentijn A.; Barraclough R.; Rudland P.; Rahmatalla N.; Martin-Hirsch P.; Stringfellow H.; Decruze S.B.; Hapangama D.K.; High AGR2 protein is a feature of low grade endometrial cancer cells. Oncotarget 2018,9(59),31459-31472","journal-title":"Oncotarget"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1007\/s13577-020-00356-4","volume":"33","author":"Gong W.","year":"2020","unstructured":"Gong W.; Ekmu B.; Wang X.; Lu Y.; Wan L.; AGR2-induced glucose metabolism facilitated the progression of endometrial carcinoma via enhancing the MUC1\/HIF-1&#x3B1; pathway. Hum Cell 2020,33(3),790-800","journal-title":"Hum Cell"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3389\/fonc.2018.00341","volume":"8","author":"Lee T.Y.","year":"2018","unstructured":"Lee T.Y.; Martinez-Outschoorn U.E.; Schilder R.J.; Kim C.H.; Richard S.D.; Rosenblum N.G.; Johnson J.M.; Metformin as a therapeutic target in endometrial cancers. Front Oncol 2018,8,341","journal-title":"Front Oncol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41416-019-0627-y","volume":"122","author":"Sivalingam V.N.","year":"2020","unstructured":"Sivalingam V.N.; Latif A.; Kitson S.; McVey R.; Finegan K.G.; Marshall K.; Lisanti M.P.; Sotgia F.; Stratford I.J.; Crosbie E.J.; Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin. Br J Cancer 2020,122(1),62-71","journal-title":"Br J Cancer"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ygyno.2017.07.120","volume":"147","author":"Meireles C.G.","year":"2017","unstructured":"Meireles C.G.; Pereira S.A.; Valadares L.P.; R&#xEA;go D.F.; Simeoni L.A.; Guerra E.N.S.; Lofrano-Porto A.; Effects of metformin on endometrial cancer: Systematic review and meta-analysis. Gynecol Oncol 2017,147(1),167-180","journal-title":"Gynecol Oncol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.maturitas.2017.04.001","volume":"101","author":"Perez-Lopez F.R.","year":"2017","unstructured":"Perez-Lopez F.R.; Pasupuleti V.; Gianuzzi X.; Palma-Ardiles G.; Hernandez-Fernandez W.; Hernandez A.V.; Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus. Maturitas 2017,101,6-11","journal-title":"Maturitas"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2016.03.027","volume":"376","author":"Calgani A.","year":"2016","unstructured":"Calgani A.; Delle Monache S.; Cesare P.; Vicentini C.; Bologna M.; Angelucci A.; Leptin contributes to long-term stabilization of HIF-1&#x3B1; in cancer cells subjected to oxygen limiting conditions. Cancer Lett 2016,376(1),1-9","journal-title":"Cancer Lett"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1196\/annals.1397.013","volume":"1095","author":"Koda M.","year":"2007","unstructured":"Koda M.; Sulkowska M.; Wincewicz A.; Kanczuga-Koda L.; Musiatowicz B.; Szymanska M.; Sulkowski S.; Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer. Ann N Y Acad Sci 2007,1095(1),90-98","journal-title":"Ann N Y Acad Sci"},{"key":"ref=74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066388","volume":"8","author":"Sceneay J.","year":"2013","unstructured":"Sceneay J.; Liu M.C.P.; Chen A.; Wong C.S.F.; Bowtell D.D.L.; M&#xF6;ller A.; The antioxidant N-acetylcysteine prevents HIF-1 stabilization under hypoxia in vitro but does not affect tumorigenesis in multiple breast cancer models in vivo. PLoS One 2013,8(6)","journal-title":"PLoS One"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1055\/s-0029-1240900","volume":"76","author":"Tomczyk M.","year":"2010","unstructured":"Tomczyk M.; Tumanov A.; Zaniewska A.; Surazynski A.; The potential mechanism of tiliroside-dependent inhibition of t-butylhydroperoxide-induced oxidative stress in endometrial carcinoma cells. Planta Med 2010,76(10),963-968","journal-title":"Planta Med"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nchembio863","volume":"3","author":"Ozer A.","year":"2007","unstructured":"Ozer A.; Bruick R.K.; Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one? Nat Chem Biol 2007,3(3),144-153","journal-title":"Nat Chem Biol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"13604","DOI":"10.1073\/pnas.0506390102","volume":"102","author":"Chen Q.","year":"2005","unstructured":"Chen Q.; Espey M.G.; Krishna M.C.; Mitchell J.B.; Corpe C.P.; Buettner G.R.; Shacter E.; Levine M.; Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA 2005,102(38),13604-13609","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12253-008-9063-7","volume":"15","author":"Chen C.","year":"2009","unstructured":"Chen C.; Sun J.; Liu G.; Chen J.; Effect of small interference RNA targeting HIF-1&#x3B1; mediated by rAAV combined L: -ascorbate on pancreatic tumors in athymic mice. Pathol Oncol Res 2009,15(1),109-114","journal-title":"Pathol Oncol Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"11105","DOI":"10.1073\/pnas.0804226105","volume":"105","author":"Chen Q.","year":"2008","unstructured":"Chen Q.; Espey M.G.; Sun A.Y.; Pooput C.; Kirk K.L.; Krishna M.C.; Khosh D.B.; Drisko J.; Levine M.; Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci USA 2008,105(32),11105-11109","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"5749","DOI":"10.1158\/0008-5472.CAN-10-0263","volume":"70","author":"Kuiper C.","year":"2010","unstructured":"Kuiper C.; Molenaar I.G.M.; Dachs G.U.; Currie M.J.; Sykes P.H.; Vissers M.C.M.; Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer. Cancer Res 2010,70(14),5749-5758","journal-title":"Cancer Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1124\/mol.108.051516","volume":"75","author":"Feng W.","year":"2009","unstructured":"Feng W.; Ye F.; Xue W.; Zhou Z.; Kang Y.J.; Copper regulation of hypoxia-inducible factor-1 activity. Mol Pharmacol 2009,75(1),174-182","journal-title":"Mol Pharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"14296","DOI":"10.1038\/srep14296","volume":"5","author":"Kim K.K.","year":"2015","unstructured":"Kim K.K.; Abelman S.; Yano N.; Ribeiro J.R.; Singh R.K.; Tipping M.; Moore R.G.; Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1&#x3B1; in cancer cells. Sci Rep 2015,5(1),14296","journal-title":"Sci Rep"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.addr.2011.01.010","volume":"63","author":"Veiseh O.","year":"2011","unstructured":"Veiseh O.; Kievit F.M.; Ellenbogen R.G.; Zhang M.; Cancer cell invasion: treatment and monitoring opportunities in nanomedicine. Adv Drug Deliv Rev 2011,63(8),582-596","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1083\/jcb.200909003","volume":"188","author":"Friedl P.","year":"2010","unstructured":"Friedl P.; Wolf K.; Plasticity of cell migration: a multiscale tuning model. J Cell Biol 2010,188(1),11-19","journal-title":"J Cell Biol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1535-6108(03)00085-0","volume":"3","author":"Pennacchietti S.","year":"2003","unstructured":"Pennacchietti S.; Michieli P.; Galluzzo M.; Mazzone M.; Giordano S.; Comoglio P.M.; Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003,3(4),347-361","journal-title":"Cancer Cell"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.anndiagpath.2016.01.004","volume":"22","author":"Abouhashem N.S.","year":"2016","unstructured":"Abouhashem N.S.; Ibrahim D.A.; Mohamed A.M.; Prognostic implications of epithelial to mesenchymal transition related proteins (E-cadherin, Snail) and hypoxia inducible factor 1&#x3B1; in endometrioid endometrial carcinoma. Ann Diagn Pathol 2016,22,1-11","journal-title":"Ann Diagn Pathol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4161\/cbt.22625","volume":"14","author":"Tanaka Y.","year":"2013","unstructured":"Tanaka Y.; Terai Y.; Kawaguchi H.; Fujiwara S.; Yoo S.; Tsunetoh S.; Takai M.; Kanemura M.; Tanabe A.; Ohmichi M.; Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer. Cancer Biol Ther 2013,14(1),13-19","journal-title":"Cancer Biol Ther"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/jjco\/hys237","volume":"43","author":"Feng Z.","year":"2013","unstructured":"Feng Z.; Gan H.; Cai Z.; Li N.; Yang Z.; Lu G.; Chen J.; Aberrant expression of hypoxia-inducible factor 1&#x3B1;, TWIST and E-cadherin is associated with aggressive tumor phenotypes in endometrioid endometrial carcinoma. Jpn J Clin Oncol 2013,43(4),396-403","journal-title":"Jpn J Clin Oncol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s13258-019-00901-y","volume":"42","author":"Wan J.","year":"2020","unstructured":"Wan J.; Qin J.; Cao Q.; Hu P.; Zhong C.; Tu C.; Hypoxia-induced PLOD2 regulates invasion and epithelial-mesenchymal transition in endometrial carcinoma cells. Genes Genomics 2020,42(3),317-324","journal-title":"Genes Genomics"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"8679","DOI":"10.18632\/oncotarget.14412","volume":"8","author":"Yang X.","year":"2017","unstructured":"Yang X.; Zhang X.; Wu R.; Huang Q.; Jiang Y.; Qin J.; Yao F.; Jin G.; Zhang Y.; DPPIV promotes endometrial carcinoma cell proliferation, invasion and tumorigenesis. Oncotarget 2017,8(5),8679-8692","journal-title":"Oncotarget"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm0603-677","volume":"9","author":"Pugh C.W.","year":"2003","unstructured":"Pugh C.W.; Ratcliffe P.J.; Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003,9(6),677-684","journal-title":"Nat Med"},{"key":"ref=92","first-page":"219","volume":"29","author":"Horr&#xE9;e N.","year":"2007","unstructured":"Horr&#xE9;e N.; van Diest P.J.; van der Groep P.; Sie-Go D.M.; Heintz A.P.; Hypoxia and angiogenesis in endometrioid endometrial carcinogenesis. Cell Oncol 2007,29(3),219-227","journal-title":"Cell Oncol"},{"key":"ref=93","first-page":"4285","volume":"21","author":"Koukourakis M.I.","year":"2001","unstructured":"Koukourakis M.I.; Tumour angiogenesis and response to radiotherapy. Anticancer Res 2001,21(6B),4285-4300","journal-title":"Anticancer Res"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/cncr.10774","volume":"95","author":"Sivridis E.","year":"2002","unstructured":"Sivridis E.; Giatromanolaki A.; Gatter K.C.; Harris A.L.; Koukourakis M.I.; Tumor and Angiogenesis Research Group. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer 2002,95(5),1055-1063","journal-title":"Cancer"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5152\/jtgga.2012.02","volume":"13","author":"Aybatl\u0131 A.","year":"2012","unstructured":"Aybatl\u0131 A.; Say\u0131n C.; Kaplan P.B.; Varol F.; Altaner S.; S&#xFC;t N.; The investigation of tumoral angiogenesis with HIF-1 alpha and microvessel density in women with endometrium cancer. J Turk Ger Gynecol Assoc 2012,13(1),37-44","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"39676","DOI":"10.18632\/oncotarget.5344","volume":"6","author":"Bredholt G.","year":"2015","unstructured":"Bredholt G.; Mannelqvist M.; Stefansson I.M.; Birkeland E.; B&#xF8; T.H.; &#xD8;yan A.M.; Trovik J.; Kalland K.H.; Jonassen I.; Salvesen H.B.; Wik E.; Akslen L.A.; Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses. Oncotarget 2015,6(37),39676-39691","journal-title":"Oncotarget"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11010-010-0395-8","volume":"340","author":"Karna E.","year":"2010","unstructured":"Karna E.; Szoka L.; Palka J.A.; Betulinic acid inhibits the expression of hypoxia-inducible factor 1&#x3B1; and vascular endothelial growth factor in human endometrial adenocarcinoma cells. Mol Cell Biochem 2010,340(1-2),15-20","journal-title":"Mol Cell Biochem"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","volume":"66","author":"Clarke M.F.","year":"2006","unstructured":"Clarke M.F.; Dick J.E.; Dirks P.B.; Eaves C.J.; Jamieson C.H.M.; Jones D.L.; Visvader J.; Weissman I.L.; Wahl G.M.; Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006,66(19),9339-9344","journal-title":"Cancer Res"},{"key":"ref=99","first-page":"3579","volume":"97","author":"Yuan L.","year":"2017","unstructured":"Yuan L.; Jiang Z.M.; Chen X.H.; Bian X.Y.; Li Y.X.; Ma X.F.; Liu X.Z.;  Hypoxia inducible factor-1&#x3B1; deSUMOylation reduces the stemness maintenance ability of endometrial cancer stem cell and increases its chemosensitivity Zhonghua Yi Xue Za Zhi 2017,97(45),3579-3582","journal-title":"Hypoxia inducible factor-1&#x3B1; deSUMOylation reduces the stemness maintenance ability of endometrial cancer stem cell and increases its chemosensitivity Zhonghua Yi Xue Za Zhi"},{"key":"ref=100","first-page":"83","volume":"3","author":"Shukla G.C.","year":"2011","unstructured":"Shukla G.C.; Singh J.; Barik S.; MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions. Mol Cell Pharmacol 2011,3(3),83-92","journal-title":"Mol Cell Pharmacol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","volume":"302","author":"Zhang B.","year":"2007","unstructured":"Zhang B.; Pan X.; Cobb G.P.; Anderson T.A.; microRNAs as oncogenes and tumor suppressors. Dev Biol 2007,302(1),1-12","journal-title":"Dev Biol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.4161\/cc.9.6.11006","volume":"9","author":"Chan S.Y.","year":"2010","unstructured":"Chan S.Y.; Loscalzo J.; MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 2010,9(6),1072-1083","journal-title":"Cell Cycle"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00424-010-0910-5","volume":"461","author":"Pocock R.","year":"2011","unstructured":"Pocock R.; Invited review: decoding the microRNA response to hypoxia. Pflugers Arch 2011,461(3),307-315","journal-title":"Pflugers Arch"},{"key":"ref=104","first-page":"399","volume":"20","author":"Xu T-X.","year":"2016","unstructured":"Xu T-X.; Zhao S-Z.; Dong M.; Yu X-R.; Hypoxia responsive miR-210 promotes cell survival and autophagy of endometriotic cells in hypoxia. Eur Rev Med Pharmacol Sci [Internet]2016,20(3),399-406","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3892\/or.2017.5717","volume":"38","author":"Eismann J.","year":"2017","unstructured":"Eismann J.; Hirschfeld M.; Erbes T.; R&#xFC;cker G.; J&#xE4;ger M.; Ritter A.; Weiss D.; Gitsch G.; Mayer S.; Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro. Oncol Rep 2017,38(2),993-1004","journal-title":"Oncol Rep"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/molehr\/gav054","volume":"21","author":"Hsiao K-Y.","year":"2015","unstructured":"Hsiao K-Y.; Wu M-H.; Chang N.; Yang S-H.; Wu C-W.; Sun H-S.; Tsai S.J.; Coordination of AUF1 and miR-148a destabilizes DNA methyltransferase 1 mRNA under hypoxia in endometriosis. Mol Hum Reprod 2015,21(12),894-904","journal-title":"Mol Hum Reprod"},{"key":"ref=107","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2019.06.028","author":"Penolazzi L.","year":"2019","unstructured":"Penolazzi L.; Bonaccorsi G.; Gaf&#xE0; R.; Ravaioli N.; Gabriele D.; Bosi C.; Lanza G.; Greco P.; Piva R.; SLUG\/HIF1-&#x3B1;\/miR-221 regulatory circuit in endometrial cancer. Gene 2019","journal-title":"Gene"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3892\/mmr.2019.10386","volume":"20","author":"Shen J.","year":"2019","unstructured":"Shen J.; Chen L.; Cheng J.; Jin X.; Mu Y.; Li Q.; Xia L.; Gao Y.; Xia Y.; Circular RNA sequencing reveals the molecular mechanism of the effects of acupuncture and moxibustion on endometrial receptivity in patients undergoing infertility treatment. Mol Med Rep 2019,20(2),1959-1965","journal-title":"Mol Med Rep"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3727\/096504018X15202988139874","volume":"27","author":"Qu J.","year":"2018","unstructured":"Qu J.; Zhang L.; Li L.; Su Y.; miR-148b functions as a tumor suppressor by targeting endoplasmic reticulum metallo protease 1 in human endometrial cancer cells. Oncol Res 2018,27(1),81-88","journal-title":"Oncol Res"},{"key":"ref=110","first-page":"4735","volume":"8","author":"Dai L.","year":"2015","unstructured":"Dai L.; Lou W.; Zhu J.; Zhou X.; Di W.; MiR-199a inhibits the angiogenic potential of endometrial stromal cells under hypoxia by targeting HIF-1&#x3B1;\/VEGF pathway. Int J Clin Exp Pathol 2015,8(5),4735-4744","journal-title":"Int J Clin Exp Pathol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"E1515","DOI":"10.1210\/jc.2012-1450","volume":"97","author":"Lin S-C.","year":"2012","unstructured":"Lin S-C.; Wang C-C.; Wu M-H.; Yang S-H.; Li Y-H.; Tsai S.J.; Hypoxia-induced microRNA-20a expression increases ERK phosphorylation and angiogenic gene expression in endometriotic stromal cells. J Clin Endocrinol Metab 2012,97(8),E1515-E1523","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/191789","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/191789\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/191789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T10:39:29Z","timestamp":1648377569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/191789\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":111,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201022666210224130022","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-10-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}